ABSTRACT
In the present study the risk approach using maternal risk factors for LBW newborns in Thailand is applied. The study may be considered as a managerial tool for developing local strategies and is particularly useful in maternal and child health care. The main objective is to develop a model to predict LBW outcome with an aim to screen those at risk at the level of health centres, district and provincial hospitals. Using MLR analysis, it is concluded that Model I and Model II (Table 3 and 4) can be used to predict which pregnant women are likely to deliver LBW newborns. The prediction can be made as early as the first trimester. If the prediction is shown to be accurate, the two models will be very helpful for use in Thai people. For general use, the investigators believe that Model I will be appropriate for application at the level of provincial and district hospitals, while Model II should be used at the health centre level peripheral to the health delivery system.
Subject(s)
Case-Control Studies , Female , Humans , Infant, Low Birth Weight , Infant, Newborn , Models, Biological , Pregnancy , Pregnancy Outcome , Probability , Regression Analysis , Risk Factors , ThailandABSTRACT
The present study assesses the risk approach for maternal risk factors for LBW newborn in Thailand. This study can be considered as a managerial tool for developing local strategies and is particularly useful in the field of maternal and child health care. A summary of maternal risk factors for LBW newborn as listed in Table 7 and can be used as a health educational tool for pregnant women and as basic data for marital counseling. It can also be used to keep the public informed about the maternal risk factors for LBW newborn which will help Thai women of reproductive age avoid the chance of having such babies.
Subject(s)
Adult , Body Height , Body Weight , Case-Control Studies , Female , Humans , Infant, Low Birth Weight , Infant, Newborn , Maternal Age , Parity , Pregnancy , Pregnancy Complications , Risk Factors , ThailandABSTRACT
A total of 184 men with uncomplicated gonococcal urethritis were treated with a single oral dose of rifampicin 900 mg and erythromycin stearate 1 gm. The cure rate on day 3 was 95.1%, 175 were cured and 9 failed (4.9%). Of all the Neisseria gonorrhoeae isolated, 86 were PPNG (46.7%). There was no difference in failure rate among patients with PPNG or with non-PPNG. With the exception of self-limited gastrointestinal disturbance, side effects were minimal. The value of this combination for the treatment of uncomplicated gonococcal urethritis in men is promising and deserves further study.